KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Inventory (2016 - 2025)

Historic Inventory for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $391.6 million.

  • Idexx Laboratories' Inventory rose 45.15% to $391.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $391.6 million, marking a year-over-year increase of 45.15%. This contributed to the annual value of $381.9 million for FY2024, which is 41.94% up from last year.
  • Latest data reveals that Idexx Laboratories reported Inventory of $391.6 million as of Q3 2025, which was up 45.15% from $392.6 million recorded in Q2 2025.
  • Idexx Laboratories' Inventory's 5-year high stood at $396.0 million during Q1 2025, with a 5-year trough of $225.6 million in Q1 2021.
  • Its 5-year average for Inventory is $349.2 million, with a median of $380.3 million in 2023.
  • In the last 5 years, Idexx Laboratories' Inventory surged by 3776.97% in 2022 and then tumbled by 384.24% in 2024.
  • Quarter analysis of 5 years shows Idexx Laboratories' Inventory stood at $269.0 million in 2021, then surged by 36.72% to $367.8 million in 2022, then increased by 3.39% to $380.3 million in 2023, then rose by 0.42% to $381.9 million in 2024, then rose by 2.54% to $391.6 million in 2025.
  • Its Inventory stands at $391.6 million for Q3 2025, versus $392.6 million for Q2 2025 and $396.0 million for Q1 2025.